MGI

Chinese biotechnology company

Follow MGI on Notably News to receive short updates to your email — rarely!

2024 MGI lost more than a third of its market capitalization after the US Congress introduced legislation to prohibit American health data being sent to China.
2022 MGI was spun out from BGI Group and listed on the Shanghai stock exchange.
May 2022 A jury in Delaware ruled that Illumina infringed on two patents owned by MGI Tech's subsidiary Complete Genomics, awarding $333.8 million in damages and dismissing Illumina's claims of patent invalidity.
March 2022 Illumina successfully persuaded a U.S. District Judge to extend restrictions on MGI America selling its CoolMPS sequencers in the United States until August 2022.
November 2021 A federal jury in California found MGI America had infringed Illumina, Inc.'s patents, awarding Illumina $8 million in damages.
September 2021 MGI won approval for its IPO on Shanghai Stock Exchange STAR Market's high-tech board.
December 2020 MGI submitted its IPO application to Shanghai Stock Exchange STAR Market.
May 2020 MGI raised $1 billion in series B funding from IDG Capital and CPE China Fund.
October 31 2019 Senate Finance Committee Chairman Chuck Grassley and Senator Marco Rubio wrote a joint letter to Department of Health and Human Services Secretary Alex Azar and CMS Administrator Seema Verma, expressing concerns about MGI's potential financing for processing American citizens' genomic or exome data.
May 2019 Complete Genomics, a research subsidiary of MGI, filed a lawsuit against Illumina alleging patent infringement on 'two-channel' DNA sequencing technology, targeting multiple Illumina sequencing platforms and related kits.
June 2018 Complete Genomics officially became part of MGI after relocating to San Jose following its initial acquisition by BGI Group.
2016 MGI was founded as a subsidiary of BGI Group, specializing in manufacturing high-throughput genetic sequencing systems and products for life sciences and health care sectors.
March 2013 BGI Group acquired Complete Genomics, marking a significant strategic move in the genomics industry.

This contents of the box above is based on material from the Wikipedia article MGI (company), which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.

See Also